Bayer and Alara Imaging partner to standardize CT radiation doses

Bayer and Alara Imaging are partnering to optimize radiation doses patients receive during CT scans, the companies announced Wednesday. 

California-based Alara Imaging is a software company that specializes in solutions that enable organizations to “securely perform modern medical imaging integration tasks.” The company’s collaboration with Bayer is centered on Alara’s dose tools, which ensure radiation doses are accurately measured and optimized to prioritize patient safety. 

The software will be integrated with Bayer’s Calantic platform— a suite of applications intended to optimize clinical workflows by triaging and prioritizing critical findings, improving disease detection and automating tasks for radiologists. The integration of Alara’s software will serve as a tool ensure organizations’ compliance with the Centers for Medicare & Medicaid Services’ (CMS) new electronic clinical quality measures, or eCQMs. For Alara’s part, the company will assist in converting radiation dose data from Calantic into a format suitable for CMS’ eCQMs. 

“Because of limitations in eCQM formats, they cannot currently access and consume elements from these radiology sources,” Alara’s website explains. “Alara translation software was developed to transform primary data into a format that can be ingested by these new eCQMs.” 

“Bayer is committed to helping Radimetrics customers by engaging with Alara to support their institutions’ compliance with the new Hospital Quality Reporting eCQMs by leveraging the Alara gateway,” Rich Dewit, Bayer’s global head, digital solutions, said in a statement. 

In the same release, Nate Mazonson, CEO and co-founder of Alara said the company “is proud to collaborate with Bayer to support health systems across the U.S. with these important patient safety measures.” 

Bayer launched its cloud-hosted Calantic Digital Solutions platform, which includes AI-enabled programs, in June of 2022. The platform has since led to Bayer inking multiple partnerships with big name companies, like Rad AI and Google, looking to integrate Calantic’s AI capabilities into their own workflows and product development plans. 

Learn more about the new partnership here

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She began covering the medical imaging industry for Innovate Healthcare in 2021.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.